579 results on '"Gillies A"'
Search Results
2. Data from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
3. Supplemental Figure Legends from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
4. Figure S1 from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
5. Data from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
6. Supplemental Figure Legends from Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
7. Supplemental Figure 6 from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
8. Data from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice
9. Figure S3 from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice
10. Figure S6 from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
11. Table S1 from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
12. Supplemental Material from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution
13. SUPPLEMENTAL MATERIALS from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
14. Data from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models
15. Data from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
16. Supplementary Figure 1 from A Low-Toxicity IL-2–Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
17. Supplementary Figure 5 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
18. Data from Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
19. Table S1 from Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice
20. Data from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
21. Supplemental Figures and Tables from An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
22. Supplementary figure legends from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
23. Supplementary Figure 3 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
24. Supplementary Methods from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer
25. Supplementary Methods from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
26. Supplementary FIgure 2 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
27. Table S3 from Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
28. Supplementary Table S3 from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models
29. Data from Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution
30. Supplementary Figures 1-6 from Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes
31. Supplementary Data from Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer
32. Supplementary Material and Methods from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models
33. Supplementary Data from A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
34. Supplementary Figure 1 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
35. Supplementary Figures 1-6 from Enhanced targeting with heterobivalent ligands
36. Supplementary Table S1 from Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer
37. Supplementary Methods from Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer
38. Supplementary Figure 4 from Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer
39. Data from Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer
40. Supplementary Figures 1-3 from Modulation of the Tumor Microvasculature by Phosphoinositide-3 Kinase Inhibition Increases Doxorubicin Delivery In Vivo
41. Supplement from Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
42. Supplementary Figures from Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models
43. Data from Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature
44. Supplemental Figure 6 from In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
45. Supplemental Figures 1 through 5 from Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
46. Supplemental Figure 5 from In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
47. Data from The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion
48. Supplementary Table 1, Figures 1-3 from Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
49. Video 2 from Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
50. Supplementary Figure 3 from Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.